Sonde Health
Uses a few seconds of speech to track changes in mental fitness and health over time.
What they do
Sonde Health builds vocal biomarker technology that listens for subtle changes in speech linked to depression, anxiety, cognitive change and respiratory conditions. Its platform is licensed into apps and devices so health checks can run quietly in the background of products people already use.
The record
- Vertical
- Mental & Behavioural Health
- Sub-segment
- Voice biomarkers
- Product type
- Platform software
- Stage
- Series B
- Headquarters
- Boston, Massachusetts
- Region
- North America
- Founded
- 2015
- Total funding
- $53M raised
Notable investors: PureTech Health, M Ventures.